B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

Humans are infected with two distinct strains (Type 1 (T1) and Type 2 (T2)) of Epstein-Barr virus (EBV) that differ substantially in their EBNA2 and EBNA 3A/B/C latency genes and the ability to transform B cells in vitro. While most T1 EBV strains contain the “prototype” form of the BZLF1 immediate-...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Masters, James C., Huebner, Shane M., Ohashi, Makoto, Bristol, Jillian A., Benner, Bayleigh E., Barlow, Elizabeth A., Turk, Gail L., Nelson, Scott E., Baiu, Dana C., Van Sciver, Nicholas, Ranheim, Erik A., Gumperz, Jenny, Sherer, Nathan M., Farrell, Paul J., Johannsen, Eric C., Kenney, Shannon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046292/
https://www.ncbi.nlm.nih.gov/pubmed/32059024
http://dx.doi.org/10.1371/journal.ppat.1008365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046292/
https://www.ncbi.nlm.nih.gov/pubmed/32059024
http://dx.doi.org/10.1371/journal.ppat.1008365

Ejemplares similares